dactinomycin has been researched along with Beckwith-Wiedemann Syndrome in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hayashi, Y; Hirato, J; Kuroiwa, M; Park, MJ; Sakamoto, J; Shimada, A; Sotomatsu, M; Suzuki, N | 1 |
Beese, RC; Jeanes, AC; McHugh, K; Ramsay, AD | 1 |
2 other study(ies) available for dactinomycin and Beckwith-Wiedemann Syndrome
Article | Year |
---|---|
Manifestation of alveolar rhabdomyosarcoma as primary cutaneous lesions in a neonate with Beckwith-Wiedemann syndrome.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Beckwith-Wiedemann Syndrome; Bone Marrow Transplantation; Camptothecin; Cyclophosphamide; Dactinomycin; Humans; Immunohistochemistry; In Situ Hybridization, Fluorescence; Infant, Newborn; Irinotecan; Potassium Channels, Voltage-Gated; Rhabdomyosarcoma, Alveolar; Skin Neoplasms; Transcription, Genetic; Vincristine | 2009 |
Fatty degeneration in a Wilms' tumour after chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Beckwith-Wiedemann Syndrome; Cardiac Surgical Procedures; Combined Modality Therapy; Dactinomycin; Doxorubicin; Female; Heart Septal Defects, Atrial; Humans; Infant; Kidney Neoplasms; Nephrectomy; Tomography, X-Ray Computed; Vincristine; Wilms Tumor | 2002 |